BACKGROUND The use of antenatal steroid therapy is common in pregnancy. In early
pregnancy, steroids may be used in women for the treatment of recurrent miscarriage or fetal …

OBJECTIVES: To assess the benefits and risks of antenatal corticosteroid therapy for fetal
maturation. OPTIONS: To administer antenatal corticosteroids or not to women at risk of …

Corticosteroid administration before anticipated preterm birth is one of the most important
antenatal therapies available to improve newborn outcomes. A single course of …

Antenatal corticosteroids are standard of care for pregnancies at risk of preterm delivery
between 24-34 weeks' gestational age. Recent trials demonstrate modest benefits from …

OBJECTIVE: To conduct a population-based study to assess rates of optimal, suboptimal,
and questionably appropriate administration of antenatal corticosteroid (betamethasone or …

Corticosteroid treatment of pregnant women at risk for preterm delivery enhances fetal lung
maturity and improves neonatal outcomes.'Despite convincing evidence of these effects, a …

No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

The administration of antenatal corticosteroids has been widely adopted as the standard of
care in the management of pregnancies at risk for preterm delivery before 37 weeks of …

BACKGROUND Despite extensive studies of the developmental consequences of increased
glucocorticoid exposure in mid-to late pregnancy, relatively little is known regarding the …

The practice of antenatal corticosteroid administration in pregnancies of 24–34 weeks of
gestation that are at risk of preterm delivery was adopted over 20 years after the first …